Opting for Contralateral Prophylactic Mastectomy Linked With Improved QoL

Choice for contralateral prophylactic mastectomy (CPM) was associated with an improvement in breast satisfaction and psychosocial well-being.
Choice for contralateral prophylactic mastectomy (CPM) was associated with an improvement in breast satisfaction and psychosocial well-being.

Choice for contralateral prophylactic mastectomy (CPM) was associated with an improvement in breast satisfaction and psychosocial well-being, a study published in the Journal of Clinical Oncology has shown.1

CPM is a risk-reducing procedure in patients with breast cancer, either noninvasive or invasive. Although CPMs have become more widely used, there is no apparent survival benefit for patients who do not harbor a BRCA1 or BRCA2 mutation and there is limited evidence on the impact of its use on quality of life.

For the study, researchers surveyed 7619 female volunteers from the Army of Women who had a history of breast cancer surgery. Of those, 3977 underwent a mastectomy and 1598 had a CPM.

Researchers found that women undergoing CPM were more likely to be younger than those who did not opt for CPM.

Analyses of patient-reported outcomes showed that average breast satisfaction was higher among those who received a CPM (P<.001) and average physical well-being was reduced in the CPM group compared with those who did not undergo a CPM (P<.001).

Continue Reading Below

Multivariate analyses also demonstrate higher breast satisfaction and psychosocial well-being among patients in the CPM group, but there were no differences between the CPM and no-CPM groups in other quality-of-life domains.

The findings ultimately suggest that patient-reported outcomes data should be considered when counseling women who are contemplating CPM as a breast cancer treatment option.

REFERENCE

1. Hwang ES, Locklear TD, Rushing CN, et al. Patient-reported outcomes after choice for contralateral prophylactic mastectomy [published online ahead of print March 7, 2016]. J Clin Oncol. doi:10.1200/JCO.2015.61.5427.

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs